Qi, Min-You <br/><br/>
A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, and PLB in rats.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Jun 2006 
 - 729-35 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/01.fjc.0000211765.52012.aa  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Aspartic Acid Endopeptidases--biosynthesis<br/>Blood Pressure<br/>Blotting, Western<br/>Calcium-Binding Proteins--biosynthesis<br/>Cardiomyopathies--drug therapy<br/>Diabetes Complications--drug therapy<br/>Diabetes Mellitus, Experimental<br/>Down-Regulation<br/>Endothelin Receptor Antagonists<br/>Endothelin-Converting Enzymes<br/>Heart Rate<br/>Male<br/>Metalloendopeptidases--biosynthesis<br/>Myocardium--metabolism<br/>Nitric Oxide Synthase Type II--biosynthesis<br/>Organ Size<br/>Oxidative Stress<br/>Pyrazoles--therapeutic use<br/>RNA, Messenger--analysis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Ryanodine Receptor Calcium Release Channel--biosynthesis<br/>Sarcoplasmic Reticulum Calcium-Transporting ATPases--biosynthesis<br/>Streptozocin<br/>Tacrolimus Binding Protein 1A--biosynthesis<br/>Up-Regulation<br/>Vasoconstrictor Agents--therapeutic use